Cancer Resource Center of the Finger Lakes
Ultima Vez Modificado: 10 de febrero del 2011
Cancer and hope are two topics that often intersect.
People with cancer sometimes wonder if maintaining hope in the face of a grim diagnosis is a good idea or a bad idea.
My response is that hope is always good, but it's a mistake to define hope strictly in the context of being cured.
When a person is first diagnosed with cancer, hope and cure do overlap. People hope that they will be cured. Even if the survival rate of that type of cancer is only 10 percent, somebody has to be in that 10 percent and it might as well be you.
Or it might be said, "People with your cancer can expect to live about 12 months." What that means is that half of the people with your cancer will live longer than 12 months.
Statistics provide guideposts, but they don't dictate what will happen to a specific person.
Of course, cancer can metastasize or otherwise advance to the point that a cure is unrealistic.
But does this mean giving up hope? No, not at all. But it does mean reframing your concept of hope to something other than a cure.
Many people who can't be cured can hope for months or years of continuing to live with a good quality of life.
Even people with a terminal diagnosis can and should have hope. The hope may be as modest as having a good weekend or as significant as a reconciliation with an estranged family member.
Hope is somehow at the core of our being human, even when one's current situation is difficult. Thich Nhat Hanh wrote: "Hope is important because it can make the present moment less difficult to bear. If we believe that tomorrow will be better, we can bear a hardship today."
And there is the hope that our lives have had and will continue to have meaning.
Hope is always present.
Bob is the Executive Director of the Cancer Resource Center. His articles about living with cancer appear regularly in the Ithaca Journal. He can be reached at firstname.lastname@example.org
Reprinted with Permission of the Ithaca Journal
Original publication date: February 4, 2011.
Sep 22, 2010 - No new evidence has emerged warranting a change in the U.S. Preventive Services Task Force's 2004 conclusion that screening asymptomatic men for testicular cancer is unlikely to offer benefits over clinical detection, according to a literature review in the Sept. 21 issue of the Annals of Internal Medicine.
Sep 22, 2010
Feb 11, 2011